Enliven Therapeutics, Inc.
Industry: Life Sciences ・ $ELVN on Nasdaq
Insider Sale
+$316,035
-100%
Shares
Shares Volume: 11,488 Shares
Average Share Price: $27.51
INSIDER
Hohl Benjamin
CHIEF FINANCIAL OFFICER (Officer)
reported on Oct 8 2024
traded on Oct 4 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 0 |
| PURCHASES/SALES 1Y | 0 / 17 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $106,113.49 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 4 |
| PURCHASES/SALES 1Y | 0 / 87 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $914,679.33 |
| COMPANY PREVIOUS TRADES |